Hoxb13, a potential prognostic biomarker for prostate cancer

Allal Ouhtit, Mohammed N. Al-Kindi, Parvathy R. Kumar, Ishita Gupta, Somya Shanmuganathan, Yahya Tamimi

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

HOXB13, a member of the homeobox proteins family, is a key regulator of the epithelial differentiation in the prostate gland. HOXB13 is overexpressed during malignant progression of the prostatic tissue and suspected to contribute in the pathogenesis of the prostate gland. In androgen deprived conditions, HOXB13 is thought to act through inhibition of the tumour suppressor protein p21. Since HOXB13 has a multifaceted role in ventral prostate development, its critical partners in the cascade need to be elucidated for a further understanding of its role in prostate malignancy. In this report, we review the functions attributed to HOXB13, by highlighting the most recent findings supporting the hypothesis that HOXB13 might serve as a novel biomarker for the prognosis of prostate cancer.

Original languageEnglish
Pages (from-to)40-45
Number of pages6
JournalFrontiers in Bioscience - Elite
Volume8
Publication statusPublished - 2016

Fingerprint

Tumor Suppressor Proteins
Homeodomain Proteins
Biomarkers
Androgens
Prostate
Prostatic Neoplasms
Tissue
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ouhtit, A., Al-Kindi, M. N., Kumar, P. R., Gupta, I., Shanmuganathan, S., & Tamimi, Y. (2016). Hoxb13, a potential prognostic biomarker for prostate cancer. Frontiers in Bioscience - Elite, 8, 40-45.

Hoxb13, a potential prognostic biomarker for prostate cancer. / Ouhtit, Allal; Al-Kindi, Mohammed N.; Kumar, Parvathy R.; Gupta, Ishita; Shanmuganathan, Somya; Tamimi, Yahya.

In: Frontiers in Bioscience - Elite, Vol. 8, 2016, p. 40-45.

Research output: Contribution to journalReview article

Ouhtit, A, Al-Kindi, MN, Kumar, PR, Gupta, I, Shanmuganathan, S & Tamimi, Y 2016, 'Hoxb13, a potential prognostic biomarker for prostate cancer', Frontiers in Bioscience - Elite, vol. 8, pp. 40-45.
Ouhtit A, Al-Kindi MN, Kumar PR, Gupta I, Shanmuganathan S, Tamimi Y. Hoxb13, a potential prognostic biomarker for prostate cancer. Frontiers in Bioscience - Elite. 2016;8:40-45.
Ouhtit, Allal ; Al-Kindi, Mohammed N. ; Kumar, Parvathy R. ; Gupta, Ishita ; Shanmuganathan, Somya ; Tamimi, Yahya. / Hoxb13, a potential prognostic biomarker for prostate cancer. In: Frontiers in Bioscience - Elite. 2016 ; Vol. 8. pp. 40-45.
@article{9343b5c7854149b58484db449d9b8a17,
title = "Hoxb13, a potential prognostic biomarker for prostate cancer",
abstract = "HOXB13, a member of the homeobox proteins family, is a key regulator of the epithelial differentiation in the prostate gland. HOXB13 is overexpressed during malignant progression of the prostatic tissue and suspected to contribute in the pathogenesis of the prostate gland. In androgen deprived conditions, HOXB13 is thought to act through inhibition of the tumour suppressor protein p21. Since HOXB13 has a multifaceted role in ventral prostate development, its critical partners in the cascade need to be elucidated for a further understanding of its role in prostate malignancy. In this report, we review the functions attributed to HOXB13, by highlighting the most recent findings supporting the hypothesis that HOXB13 might serve as a novel biomarker for the prognosis of prostate cancer.",
author = "Allal Ouhtit and Al-Kindi, {Mohammed N.} and Kumar, {Parvathy R.} and Ishita Gupta and Somya Shanmuganathan and Yahya Tamimi",
year = "2016",
language = "English",
volume = "8",
pages = "40--45",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",

}

TY - JOUR

T1 - Hoxb13, a potential prognostic biomarker for prostate cancer

AU - Ouhtit, Allal

AU - Al-Kindi, Mohammed N.

AU - Kumar, Parvathy R.

AU - Gupta, Ishita

AU - Shanmuganathan, Somya

AU - Tamimi, Yahya

PY - 2016

Y1 - 2016

N2 - HOXB13, a member of the homeobox proteins family, is a key regulator of the epithelial differentiation in the prostate gland. HOXB13 is overexpressed during malignant progression of the prostatic tissue and suspected to contribute in the pathogenesis of the prostate gland. In androgen deprived conditions, HOXB13 is thought to act through inhibition of the tumour suppressor protein p21. Since HOXB13 has a multifaceted role in ventral prostate development, its critical partners in the cascade need to be elucidated for a further understanding of its role in prostate malignancy. In this report, we review the functions attributed to HOXB13, by highlighting the most recent findings supporting the hypothesis that HOXB13 might serve as a novel biomarker for the prognosis of prostate cancer.

AB - HOXB13, a member of the homeobox proteins family, is a key regulator of the epithelial differentiation in the prostate gland. HOXB13 is overexpressed during malignant progression of the prostatic tissue and suspected to contribute in the pathogenesis of the prostate gland. In androgen deprived conditions, HOXB13 is thought to act through inhibition of the tumour suppressor protein p21. Since HOXB13 has a multifaceted role in ventral prostate development, its critical partners in the cascade need to be elucidated for a further understanding of its role in prostate malignancy. In this report, we review the functions attributed to HOXB13, by highlighting the most recent findings supporting the hypothesis that HOXB13 might serve as a novel biomarker for the prognosis of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=84983760617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983760617&partnerID=8YFLogxK

M3 - Review article

C2 - 26709644

AN - SCOPUS:84983760617

VL - 8

SP - 40

EP - 45

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

ER -